Dr. Amy L. Mcgregor, MD
Neurology (Epilepsy Physician)
At a glance
- Medical school
- Washington University School of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Washington University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Epilepsy Physician primary
TN license 39804 -
Neurology with Special Qualifications in Child Neurology Physician
TN license 39804
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Methodist Hospitals of Memphis Memphis, TN
Medical groups
- Ut Lebonheur Pediatric Specialists, Inc. (166 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Topiramate Other prescribers in Memphis, TN | 72 |
| Clobazam | 66 |
| Lamotrigine Other prescribers in Memphis, TN | 64 |
| Epidiolex (cannabidiol (cbd)) | 54 |
| Diazepam Other prescribers in Memphis, TN | 53 |
| Lacosamide Other prescribers in Memphis, TN | 50 |
| Nayzilam (midazolam) | 48 |
| Fycompa (perampanel) | 48 |
| Xcopri (cenobamate) | 35 |
| Fintepla (fenfluramine hcl) | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 19 payments worth $379 in total to this clinician.
| UCB, Inc. | $173 |
|---|---|
| Neurelis, Inc. | $109 |
| Sk Life Science, Inc. | $33.39 |
| Azurity Pharmaceuticals, Inc. | $24.56 |
| Biocodex, Inc. | $20.89 |
| Otter Pharmaceuticals, LLC | $18.52 |
| Food and Beverage | $379 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.